Home
»
Press Room
»
Genomics Market Size To Reach $72.50 Billion By 2033

Genomics Market Size To Reach $72.50 Billion By 2033

January 2026 | Report Format: Electronic (PDF)

Genomics Market Growth & Trends

The global genomics market size is estimated to reach USD 72.50 billion by 2033, registering a CAGR of 18.2% from 2026 to 2033, according to a new report by Grand View Research, Inc. Moreover, it is extensively used for a wide variety of applications, such as pharmacogenomics, and metagenomics. The emerging applications of genomics are braced up by industrial collaborations and expansions. For instance, in June 2020, Merck & Co., Inc., and 10x Genomics, Inc., collaborates to develop powerful genomics-based experiments to better understand the relationship between specific genes and disease by using 10x Genomics’ barcode technology to screen single cells using CRISPR libraries.

Technological advancements in the genomics market such as research on chromosomal instability and gene signatures utilizing unique samples from huge databases give out comprehensive insights into their clinical applicability. For instance, in June 2022, researchers from Cambridge University and the National Cancer Research Center (at Madrid, Spain) deduced to track chromosomal instability and copy number variations to understand the role of internal factors in driving such genomic alterations in cancers that are fatal in nature.

Diseases caused by genetic inheritance can cause a wide range of disease conditions such as cardiovascular, diabetes, and cancer conditions. Genetic disorders can be effectively combatted by understanding specific characteristics of an individual’s genome sequence. For instance, in November 2021, Illumina, Inc. and the Genetic Alliance, collectively declared the launch of the iHope genetic health program so as to facilitate access to whole-genome sequencing to survivors of genetic disorders across the globeDee with one-third of the efforts to support subjects in Africa.

The market is positively driven by the lucrative support from the government and other research organizations for advancement in research on the genome sequence. There has been an increasing focus on funds for data-driven initiatives on genome sequence research to derive outcomes that are helpful for the treatment of rare diseases, infectious diseases, inherited disorders, and cancers. For instance, in August 2022, Medical Device Innovation Consortium launched its somatic reference samples initiative to develop clinically relevant samples and public genomic datasets to aid the enhancement of NGS-based cancer diagnostics. Similarly, in September 2022, the Centres for Disease Control (CDC) declared 5-year awards to establish the pathogen genomics centers of excellence (PGCoE) network to foster innovation and capabilities in bioinformatics, pathogen genomics, and molecular epidemiology.

One of the most important factors anticipated to impact the genomics market is how much and to what extent the medical community will make use of available genomic information in personalized medicine. Furthermore, plummeting costs of sequencing support an increase in the adoption of whole genome sequencing. Scientists are combining the data generated from sequencing with diagnostics, which has proven effective in enhancing the personalized treatment landscape. According to a report published by OGL, as of July 2021, the UK exceeded 600,000 SARS-CoV-2 genomically sequenced tests. Genomic sequencing has been helpful in the fight against SARS-CoV-2 by quickly identifying variations that are of concern, elucidating how they spread, and halting them.

key Request a free sample copy or view report summary: Genomics Market Report

Genomics Market Report Highlights

Based on application, the functional genomics segment dominated the overall market with the largest revenue share of 32.77% in 2025, attributed to research studies aiming to understand a particular phenotypical expression of a given disease condition.
Based on deliverables, the product segment dominated the market in 2025 and is expected to grow at the fastest CAGR over the forecast period.
Based on end-use, the pharmaceutical and biotechnology companies segment led the market with market share of 54.80% in 2025, attributed to the increasing demand for use of genomics in drug discovery.
North America genomics market accounted for the largest market share of 42.25% in 2025, driven by the strong presence of leading genomics companies, high adoption of advanced sequencing technologies, and robust funding for genomic research.

Genomics Market Segmentation

Grand View Research has segmented the global genomics market based on application, deliverables, end-use, and region:

Genomics Application Outlook (Revenue, USD Million, 2021 - 2033)

Functional Genomics
- Real-time PCR
- Transfection
- SNP Analysis
- Mutational Analysis
- Microarray Analysis
- RNA Interference
Epigenomics
- Bisulfite Sequencing
- Microarray Analysis
- Chromatin Immunoprecipitation (ChIP & ChIP-Seq)
- Methylated DNA Immunoprecipitation (MeDIP)
- High Resolution Melt (HRM)
- Chromatin Accessibility Assays
Pathway Analysis
- Microarray Analysis
- Bead-based Analysis
- Proteomics Tools (2-D PAGE; yeast 2-hybrid studies)
- Real-time PCR
Biomarker Discovery
- DNA Sequencing
- Microarray Analysis
- Real-time PCR
- Mass Spectrometry
- Statistical Analysis
- Bioinformatics
Others

Genomics Deliverables Outlook (Revenue, USD Million, 2021 - 2033)

Products
- Instruments/Systems/Software
- Consumables & Reagents
Services
- NGS-based Services
- Core Genomics Services
- Biomarker Translation Services
- Computational Services
- Others